About
Investor & Media Contact:
Lumos Pharma Investor Relations
512-792-5454
ir@lumos-pharma.com
Source:
Source:
2022 GlobeNewswire, Inc., source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.53 USD | -3.44% | -4.17% | -20.44% |
Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
About
Investor & Media Contact:
Lumos Pharma Investor Relations
512-792-5454
ir@lumos-pharma.com
Source:
Source:
2022 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-20.44% | 21.24M | |
-1.59% | 41.35B | |
+42.15% | 40.38B | |
+2.89% | 39.05B | |
-12.11% | 26.67B | |
+1.90% | 24.07B | |
-23.67% | 18.36B | |
-3.72% | 11.68B | |
+21.15% | 11.6B | |
+7.55% | 11.15B |